Home › Long COVID › Washington
Pag-aaral pangklinika para sa Long COVID sa Washington
6 pag-aaral para sa Long COVID ang naghahanap ng mga kalahok sa mga site sa Washington.
Mga Lungsod sa Washington
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
- Childrens Hospital Regional Medical Center, Seattle
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
6 Months – 11 Years · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07808697A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Eastside Research Associates ( Site 3727), Redmond
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06667700A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Seattle Rheumatology Associates, Seattle
- Swedish Ambulatory Infusion Center- First Hill, Seattle
- Swedish Cancer Institute Treatment Center, Seattle
- at 6 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Swedish Medical Center, Seattle
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06631287A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Seattle
Nagre-recruitPhase 1
Edad 65 hanggang 85 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07464314Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Seattle Children's Hospital, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT03808922Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.